Recombinant multi-species JUNB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine JUNB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables sequence-specific double-stranded DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription factor AP-1 complex. Implicated in head and neck squamous cell carcinoma and melanoma. Biomarker of gastrointestinal system cancer (multiple); lung non-small cell carcinoma; and lymphoma (multiple). [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: AP-1,JUNB,Junb,Transcription factor AP-1 subunit JunB,Transcription factor JunB

Target products collectionGo to JUNB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8330-Ag-1/ GM-Tg-hg-IP8330-Ag-2 Human JUNB protein Human
GM-Tg-rg-IP8330-Ag-1/ GM-Tg-rg-IP8330-Ag-2 Rat JUNB protein Rat
GM-Tg-mg-IP8330-Ag-1/ GM-Tg-mg-IP8330-Ag-2 Mouse JUNB protein Mouse
GM-Tg-cynog-IP8330-Ag-1/ GM-Tg-cynog-IP8330-Ag-2 Cynomolgus/Rhesus macaque JUNB protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8330-Ag-1/ GM-Tg-felg-IP8330-Ag-2 Feline JUNB protein Feline
GM-Tg-cang-IP8330-Ag-1/ GM-Tg-cang-IP8330-Ag-2 Canine JUNB protein Canine
GM-Tg-bovg-IP8330-Ag-1/ GM-Tg-bovg-IP8330-Ag-2 Bovine JUNB protein Bovine
GM-Tg-equg-IP8330-Ag-1/ GM-Tg-equg-IP8330-Ag-2 Equine JUNB protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8330-Ag-1/ GM-Tg-hg-IP8330-Ag-2; GM-Tg-rg-IP8330-Ag-1/ GM-Tg-rg-IP8330-Ag-2;
GM-Tg-mg-IP8330-Ag-1/ GM-Tg-mg-IP8330-Ag-2; GM-Tg-cynog-IP8330-Ag-1/ GM-Tg-cynog-IP8330-Ag-2;
GM-Tg-felg-IP8330-Ag-1/ GM-Tg-felg-IP8330-Ag-2; GM-Tg-cang-IP8330-Ag-1/ GM-Tg-cang-IP8330-Ag-2;
GM-Tg-bovg-IP8330-Ag-1/ GM-Tg-bovg-IP8330-Ag-2; GM-Tg-equg-IP8330-Ag-1/ GM-Tg-equg-IP8330-Ag-2
Products Name JUNB protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name JUNB
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine JUNB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.